A Randomized Feasibility Trial Comparing Drospirenone and Norethindrone for Postpartum Hypertension Management in Preeclampsia
NCT07293728
·
clinicaltrials.gov ↗
PHASE4
Phase
NOT_YET_RECRUITING
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Hypertension
Preeclampsia
Interventions
DRUG:
Norethindrone 0.35 MG
DRUG:
Drospirenone
Sponsor
Oregon Health and Science University